Latest Breaking News On - Barrye greene - Page 1 : comparemela.com

Published: Dec 16, 2020   Barry Greene, a world-class leader with global experience and a significant track record of success in R&D and commercialization, joins as part of plan to accelerate the Sage mission to deliver truly transformational medicines for people with brain health disorders Jeff Jonas to assume new role of Chief Innovation Officer, Chair of the Science and Technology Forum, remaining a member of the Board and bolstering plans for further expansion of pipeline opportunities   CAMBRIDGE, Mass. (BUSINESS WIRE) SAGE Therapeutics (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating brain disorders, today announced that, as part of the Company’s plan to accelerate growth and leverage the talents of the leaders in the brain health space, Barry Greene has been appointed chief executive officer. Mr. Greene, who most recently served as president of Alnylam Pharma

United kingdomKevin starrBarrye greeneBarry greeneJeff jonasExchange commissionUniversity of pittsburghDrug administrationAlnylam pharmaceuticals incSage science technology forum of the boardOncology at millennium pharmaceuticals incAlnylam pharmaceuticalsBusiness wireTechnology forumOsage boardMillennium pharmaceuticals